S. 4426 is a bill that seeks to prohibit gender transition procedures for minors. It authorizes the Secretary of Health and Human Services to impose civil penalties on individuals who perform such procedures on minors. The bill may include additional related provisions, but these are not specified in the title.
Supporters of the bill argue that it is necessary to protect minors from undergoing irreversible medical procedures that they may later regret. They believe that the legislation will ensure that children are not subjected to potentially harmful treatments before they are mature enough to make such significant decisions.
Critics of the bill claim that it infringes on the rights of transgender youth to access necessary medical care. They argue that it could lead to negative mental health outcomes for minors who are unable to receive gender-affirming care and that it undermines the professional judgment of healthcare providers.
The primary potential conflict of interest arises from the fact that Senator Marshall's top donor industry is Health Professionals, which has donated a total of $40,000,000 to his campaign. Given that the bill S. 4426 directly impacts the health sector, specifically those involved in gender transition procedures, this presents a significant conflict. Furthermore, there has been substantial lobbying activity in this bill's policy area, with organizations such as B. Braun Medical Inc. and MBK Partners investing heavily in lobbying efforts. While it is not directly disclosed that these lobbying efforts are connected to Senator Marshall, the overlap in policy area and the significant financial contributions from the health sector to his campaign suggest a high potential for conflict of interest.
These industries are both affected by this bill and among the sponsor's top donors.
| Industry | Match Type | Related Subject | Donations |
|---|---|---|---|
| Health Professionals (H01) | Sector | Health | $40,000,000 |
| Total from overlapping industries | $40,000,000 | ||
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| BAE, KIM & LEE, LLC | THE MCKEON GROUP, INC. | $370,000 |
| MBK PARTNERS | THE MCKEON GROUP, INC. | $150,000 |
| B. BRAUN MEDICAL INC. | POLSINELLI PC | $70,000 |
| VECTOR | THE MCKEON GROUP, INC. | $40,000 |
| SOLUTION PHILIPPINES, LLC | THE MCKEON GROUP, INC. | $40,000 |
| AMERICAN PHARMACISTS ASSOCIATION | AMERICAN PHARMACISTS ASSOCIATION | $35,000 |
| D-WAVE GOVERNMENT, INC | THE MCKEON GROUP, INC. | $10,000 |
| NATIONAL ASSOCIATION OF RSVP PROGRAM DIRECTORS | THE SUSQUEHANNA GROUP | $5,000 |
| STR8 CORPORATION | BRODY GROUP L.L.C. PUBLIC AFFAIRS | undisclosed |
| WEST GULF MARITIME ASSOCIATION | WEST GULF MARITIME ASSOCIATION | undisclosed |
| CENTRAL ADMIXTURE PHARMACY SERVICES, INC. | POLSINELLI PC | undisclosed |
| CARTRIDGE TECHNOLOGIES, LLC | CHECKMATE GOVERNMENT RELATIONS | undisclosed |
| BLUE DIAMOND ATOMICS | NATURAL STATE CONSULTING AND STRATEGIES | undisclosed |
| POPLICUS INCORPORATED DBA GOVINI | CHECKMATE GOVERNMENT RELATIONS | undisclosed |
| STRYDENT AUTONOMOUS TECHNOLOGIES | POTOMAC STRATEGIC CONSULTING LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Roger Marshall, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)